DCIS Treatment Revolution: Radiotherapy Alone vs Surgery for Breast Cancer Survival

DCIS radiotherapy breast cancer surgery alternative Kefah Mokbel study ductal carcinoma in situ survival rates
Discover groundbreaking insights from a new study on ductal carcinoma in situ (DCIS) treatment.
Dr. Kefah Mokbel discusses how radiotherapy alone could replace surgery for select patients, offering excellent 10-year survival.
Key findings include:
93.2% overall survival with RT vs 78.1% without.
99.5% breast cancer-specific survival with RT.
Lower invasive progression risk.
Learn about predictors of benefit: upper-outer quadrant tumors, cribriform histology, hormone-receptor positive status.
Risk factors: larger tumors, high grade, hormone-negative.
Why it matters: Reduce overtreatment and surgical morbidity in low-risk DCIS cases.
Important caveats: Retrospective study, not RCT.
Perfect for patients and clinicians exploring personalized breast cancer therapy options.
Optimize your treatment plan with this evidence-based discussion.